COVID-19 Research: Lessons from Non-Human Primate Models
- PMID: 34452011
- PMCID: PMC8402317
- DOI: 10.3390/vaccines9080886
COVID-19 Research: Lessons from Non-Human Primate Models
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease 2019 (COVID-19). It emerged from China in December 2019 and rapidly spread across the globe, causing a pandemic with unprecedented impacts on public health and economy. Therefore, there is an urgent need for the development of curative treatments and vaccines. In humans, COVID-19 pathogenesis shows a wide range of symptoms, from asymptomatic to severe pneumonia. Identifying animal models of SARS-CoV-2 infection that reflect the clinical symptoms of COVID-19 is of critical importance. Nonhuman primates (NHPss) correspond to relevant models to assess vaccine and antiviral effectiveness. This review discusses the use of NHPs as models for COVID-19 research, with focus on the pathogenesis of SARS-CoV-2 infection, drug discovery and pre-clinical evaluation of vaccine candidates.
Keywords: COVID-19; SARS-CoV-2; drug discovery; non-human primates; pathogenesis; vaccine.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- WHO Coronavirus Disease (COVID-19) Dashboard. [(accessed on 16 April 2021)]; Available online: https://covid19.who.int.
-
- SARS-CoV-2 and Potential Airborne Transmission. [(accessed on 31 March 2021)]; Available online: https://www.cdc.gov/coronavirus/2019-ncov/more/scientific-brief-sars-cov....
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
